跳至主要内容
临床试验/NL-OMON33175
NL-OMON33175招募中2 期

Safety and feasibility of the ketogenic diet in therapy resistand paediatric recurrent or progressive pontine glioma, a pilot study - Pontine glioma and ketogenic diet

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • - recurrent or progressive pons glioma
  • - 1-18 years of age
  • - failure of treatment with radiotherapy and Temozolomide and no therapeutic options left
  • - good Dutch reading and writing (parents of caregivers)
  • - Informed Consent of parents/care givers and/or the child (when >12)
  • - willingness of children younger than 12 years to participate in the study

排除标准

  • - < 1 year or >17 year of age
  • - use of Temozolomide or other chemotherapeutic drug
  • - language barrier (parents or caregivers)
  • - current treatment with steroids of treated within 3 weeks before start of the study
  • - fatty acid disorders (like MCAD)
  • - Hypertrigyceridemia (> 10mmol/l)
  • - kidney stones
  • - diabetes mellitus
  • - pancreatitis
  • - gastro intestinal problems like persistent diarrhoea
  • - parents unable to handel dietary instructions
  • NB: use of tube feeding is NOT an exclusion criteria

研究者

相似试验